Vir Biotechnology Statistics
Total Valuation
VIR has a market cap or net worth of $695.34 million. The enterprise value is -$10.23 million.
Important Dates
The next confirmed earnings date is Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VIR has 138.24 million shares outstanding. The number of shares has increased by 1.66% in one year.
| Current Share Class | 138.24M |
| Shares Outstanding | 138.24M |
| Shares Change (YoY) | +1.66% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 4.47% |
| Owned by Institutions (%) | 56.72% |
| Float | 93.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.98 |
| Forward PS | 63.39 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.79, with a Debt / Equity ratio of 0.09.
| Current Ratio | 6.79 |
| Quick Ratio | 5.88 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.59% and return on invested capital (ROIC) is -25.97%.
| Return on Equity (ROE) | -44.59% |
| Return on Assets (ROA) | -23.52% |
| Return on Invested Capital (ROIC) | -25.97% |
| Return on Capital Employed (ROCE) | -49.85% |
| Revenue Per Employee | $51,130 |
| Profits Per Employee | -$1.42M |
| Employee Count | 408 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.54% in the last 52 weeks. The beta is 1.22, so VIR's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -50.54% |
| 50-Day Moving Average | 5.27 |
| 200-Day Moving Average | 7.15 |
| Relative Strength Index (RSI) | 39.60 |
| Average Volume (20 Days) | 1,124,994 |
Short Selling Information
The latest short interest is 11.29 million, so 8.17% of the outstanding shares have been sold short.
| Short Interest | 11.29M |
| Short Previous Month | 11.22M |
| Short % of Shares Out | 8.17% |
| Short % of Float | 12.03% |
| Short Ratio (days to cover) | 9.20 |
Income Statement
In the last 12 months, VIR had revenue of $20.86 million and -$577.65 million in losses. Loss per share was -$4.22.
| Revenue | 20.86M |
| Gross Profit | -476.87M |
| Operating Income | -583.52M |
| Pretax Income | -492.27M |
| Net Income | -577.65M |
| EBITDA | -570.61M |
| EBIT | -583.52M |
| Loss Per Share | -$4.22 |
Full Income StatementBalance Sheet
The company has $801.66 million in cash and $96.10 million in debt, giving a net cash position of $705.57 million or $5.10 per share.
| Cash & Cash Equivalents | 801.66M |
| Total Debt | 96.10M |
| Net Cash | 705.57M |
| Net Cash Per Share | $5.10 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 7.56 |
| Working Capital | 794.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$415.08 million and capital expenditures -$7.06 million, giving a free cash flow of -$422.14 million.
| Operating Cash Flow | -415.08M |
| Capital Expenditures | -7.06M |
| Free Cash Flow | -422.14M |
| FCF Per Share | -$3.05 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,797.18% |
| Pretax Margin | -2,775.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.66% |
| Shareholder Yield | -1.66% |
| Earnings Yield | -83.07% |
| FCF Yield | -60.71% |
Dividend DetailsAnalyst Forecast
The average price target for VIR is $30.25, which is 501.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.25 |
| Price Target Difference | 501.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 19.54% |
| EPS Growth Forecast (5Y) | -11.88% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VIR has an Altman Z-Score of 1.05 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 1 |
